Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004964172> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W2004964172 endingPage "272" @default.
- W2004964172 startingPage "267" @default.
- W2004964172 abstract "Objective: Propofol has been accused for increasing plasma lipid levels during continuous infusion due to its lipid content. We aimed to show the effect and the risk of propofol infusion on plasma lipid and glucose levels in patients with hyperlipidemia undergoing coronary artery bypass graft surgery (CABG), and to compare them with a midazolam used control group. Material and Methods: In this randomized controlled study, 15 patients in the propofol group had anesthesia induction with intravenous propofol 1%, 2 mg/kg, fentanyl 10-15 mcg/kg, pancuronium 0.1 mg/kg, and the anesthesia was maintained with 1% 2-5 mg/kg/h propofol infusion, fentanyl 5-10 mcg/kg/hr, and an hourly pancuronium dose of 0.03 mg/kg The anesthetia management of 15 patients in midazolam group included induction with midazolam 0.1 mg/kg, fentanyl 10-15 mcg/kg, pancuronium 0.1 mg/kg, and infusion of midazolam 0.05-0.07 mg/kg/hr, fentanyl 5-10 mcg/kg/hr, and an hourly pancuronium dose of 0.03 mg/kg Plasma lipid [total cholesterol (CHL), triglyceride (TRG), high density lipoprotein (HDL), low density lipoprotein (LDL), very low density lipoprotein (VLDL)] and glucose concentrations were measured in both groups perioperatively, at seven different time points until 72 hours after the operation. Results: The decreases of TRG and HDL levels were statistically significant in the midazolam group. There were no significant differences for the decreases in CHL, LDL and VLDL levels between the groups. In both groups, plasma glucose levels increased significantly, independent from the propofol and midazolam infusions. Conclusion: We observed that propofol and midazolam anesthesia used in patients with hyperlipidemia undergoing to CABG did not have any effect on plasma lipid or glucose levels." @default.
- W2004964172 created "2016-06-24" @default.
- W2004964172 creator A5007491271 @default.
- W2004964172 creator A5029400962 @default.
- W2004964172 creator A5039682714 @default.
- W2004964172 creator A5080936157 @default.
- W2004964172 creator A5081652720 @default.
- W2004964172 date "2014-01-01" @default.
- W2004964172 modified "2023-10-01" @default.
- W2004964172 title "Effects of Propofol and Midazolam Infusions on Serum Lipid and Glucose Levels in Hyperlipidemic Patients Undergoing Coronary Artery Bypass Surgery" @default.
- W2004964172 doi "https://doi.org/10.5336/medsci.2014-38844" @default.
- W2004964172 hasPublicationYear "2014" @default.
- W2004964172 type Work @default.
- W2004964172 sameAs 2004964172 @default.
- W2004964172 citedByCount "0" @default.
- W2004964172 crossrefType "journal-article" @default.
- W2004964172 hasAuthorship W2004964172A5007491271 @default.
- W2004964172 hasAuthorship W2004964172A5029400962 @default.
- W2004964172 hasAuthorship W2004964172A5039682714 @default.
- W2004964172 hasAuthorship W2004964172A5080936157 @default.
- W2004964172 hasAuthorship W2004964172A5081652720 @default.
- W2004964172 hasBestOaLocation W20049641721 @default.
- W2004964172 hasConcept C134018914 @default.
- W2004964172 hasConcept C2776277131 @default.
- W2004964172 hasConcept C2776814716 @default.
- W2004964172 hasConcept C2778000748 @default.
- W2004964172 hasConcept C2778163477 @default.
- W2004964172 hasConcept C2778913445 @default.
- W2004964172 hasConcept C2779091943 @default.
- W2004964172 hasConcept C2780072125 @default.
- W2004964172 hasConcept C2781072394 @default.
- W2004964172 hasConcept C42219234 @default.
- W2004964172 hasConcept C555293320 @default.
- W2004964172 hasConcept C71924100 @default.
- W2004964172 hasConcept C8243546 @default.
- W2004964172 hasConceptScore W2004964172C134018914 @default.
- W2004964172 hasConceptScore W2004964172C2776277131 @default.
- W2004964172 hasConceptScore W2004964172C2776814716 @default.
- W2004964172 hasConceptScore W2004964172C2778000748 @default.
- W2004964172 hasConceptScore W2004964172C2778163477 @default.
- W2004964172 hasConceptScore W2004964172C2778913445 @default.
- W2004964172 hasConceptScore W2004964172C2779091943 @default.
- W2004964172 hasConceptScore W2004964172C2780072125 @default.
- W2004964172 hasConceptScore W2004964172C2781072394 @default.
- W2004964172 hasConceptScore W2004964172C42219234 @default.
- W2004964172 hasConceptScore W2004964172C555293320 @default.
- W2004964172 hasConceptScore W2004964172C71924100 @default.
- W2004964172 hasConceptScore W2004964172C8243546 @default.
- W2004964172 hasIssue "2" @default.
- W2004964172 hasLocation W20049641721 @default.
- W2004964172 hasOpenAccess W2004964172 @default.
- W2004964172 hasPrimaryLocation W20049641721 @default.
- W2004964172 hasRelatedWork W1539687393 @default.
- W2004964172 hasRelatedWork W2004964172 @default.
- W2004964172 hasRelatedWork W2048474290 @default.
- W2004964172 hasRelatedWork W2115108867 @default.
- W2004964172 hasRelatedWork W2356838685 @default.
- W2004964172 hasRelatedWork W2361468386 @default.
- W2004964172 hasRelatedWork W2384209318 @default.
- W2004964172 hasRelatedWork W2405641618 @default.
- W2004964172 hasRelatedWork W2418045911 @default.
- W2004964172 hasRelatedWork W2977459963 @default.
- W2004964172 hasVolume "34" @default.
- W2004964172 isParatext "false" @default.
- W2004964172 isRetracted "false" @default.
- W2004964172 magId "2004964172" @default.
- W2004964172 workType "article" @default.